secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2026-06-15T15:31:39+00:00
Accession:  0001193125-26-270560
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences raises $4M via private placement of pre-funded warrants and options
--------------------------------------------------------------------------------

- Sold 3.88M pre-funded warrants and Series A-1/A-2 options at $1.03 per unit, gross proceeds ~$4M.
- Pre-funded warrants exercisable at $0.0001; Series A-2 options at $0.91, immediately exercisable.
- Series A-1 options exercisable at $0.91 after stockholder approval, expire five years later.
- H.C. Wainwright acted as exclusive placement agent; 7% cash fee plus placement agent warrants.
- Net proceeds to be used for working capital and general corporate purposes; offering closed June 12, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526270560/0001193125-26-270560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526270560/rkda-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-270560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer